Actinium Files Orphan Drug Application for Use of Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients Nov 23, 2015
Actinium Pharmaceuticals Further Strengthens Product Development Efforts With Senior Level Hires Nov 4, 2015
Actinium Announces Data From Actimab-A Trial has Been Accepted for Poster Presentation at American Society of Hematology Annual Meeting Oct 26, 2015
Actinium Pharmaceuticals Further Strengthens Team Adding an Accomplished Finance and Corporate Development Professional Oct 13, 2015
Actinium Targets Fourth Quarter IND Filing for Iomab-B Subsequent to Pre-IND Meeting With FDA Oct 6, 2015
